Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Tuberculosis | Research article

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study

Authors: Sulaiman Lakoh, Darlinda F. Jiba, Joseph E. Kanu, Eva Poveda, Angel Salgado-Barreira, Foday Sahr, Momodu Sesay, Gibrilla F. Deen, Tom Sesay, Wadzani Gashau, Robert A. Salata, George A. Yendewa

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

HIV infection is a growing public health problem in Sierra Leone and the wider West Africa region. The countrywide HIV prevalence was estimated at 1.7% (67,000 people), with less than 30% receiving life-saving ART in 2016. Thus, HIV-infected patients tend to present to health facilities late, with high mortality risk.

Methods

We conducted a prospective study of HIV inpatients aged ≥15 years at Connaught Hospital in Freetown—the main referral hospital in Sierra Leone—from July through September 2017, to assess associated factors and predictors of HIV-related mortality.

Results

One hundred seventy-three HIV inpatients were included, accounting for 14.2% (173/1221) of all hospital admissions during the study period. The majority were female (59.5%, 70/173), median age was 34 years, with 51.4% (89/173) of them diagnosed with HIV infection for the first time during the current hospitalization. The most common admitting diagnoses were anemia (48%, 84/173), tuberculosis (24.3%, 42/173), pneumonia (17.3%, 30/173) and diarrheal illness (15.0%, 26/173). CD4 count was obtained in 64.7% (112/173) of patients, with median value of 87 cells/μL (IQR 25–266), and was further staged as severe immunosuppression: CD4 < 100 cells/μL (50%, 56/112); AIDS: CD4 < 200 cells/μL (69.6%, 78/112); and late-stage HIV disease: CD4 < 350 cells/μL (83%, 93/112). Fifty-two patients (30.1%, 52/173) died during hospitalization, 23% (12/52) of them within the first week. The leading causes of death were anemia (23.1%, 12/52), pneumonia (19.2%, 10/52), diarrheal illness (15.4%, 8/52) and tuberculosis (13.6%, 7/52). Neurological symptoms, i.e., loss of consciousness (p = 0.04) and focal limb weakness (p = 0.04); alcohol use (p = 0.01); jaundice (p = 0.02); cerebral toxoplasmosis (p = 0.01); and tuberculosis (p = 0.04) were significantly associated with mortality; however, only jaundice (AOR 0.11, 95% CI [0.02–0.65]; p = 0.01) emerged as an independent predictor of mortality.

Conclusion

HIV-infected patients account for a substantial proportion of admissions at Connaught Hospital, with a high morbidity and in-hospital mortality burden. These findings necessitate the implementation of specific measures to enhance early HIV diagnosis and expand treatment access to all HIV-infected patients in Sierra Leone.
Literature
1.
go back to reference UNAIDS 2018. Global HIV & AIDS statistics — 2018 fact sheet. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. UNAIDS 2018. Global HIV & AIDS statistics — 2018 fact sheet. http://​www.​unaids.​org/​sites/​default/​files/​media_​asset/​UNAIDS_​FactSheet_​en.​pdf.​
3.
go back to reference Obiako RO, Muktar HM, Adeiza M, et al. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, northern Nigeria. AIDS Res Treat. 2012;2012:940580.PubMedPubMedCentral Obiako RO, Muktar HM, Adeiza M, et al. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, northern Nigeria. AIDS Res Treat. 2012;2012:940580.PubMedPubMedCentral
4.
go back to reference Saavedra A, Campinha-Bacote N, Hajjar M, et al. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu teaching hospital. Pan Afr Med J. 2017;27:48.CrossRef Saavedra A, Campinha-Bacote N, Hajjar M, et al. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu teaching hospital. Pan Afr Med J. 2017;27:48.CrossRef
5.
go back to reference Lewden C, Drabo YJ, Zannou DM, et al. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc. 2014;17:1–12.CrossRef Lewden C, Drabo YJ, Zannou DM, et al. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc. 2014;17:1–12.CrossRef
6.
go back to reference Yendewa GA, Poveda E, Yendewa SA, et al. HIV/AIDS in Sierra Leone: characterizing the hidden epidemic. AIDS Rev. 2018;20:105–14. Yendewa GA, Poveda E, Yendewa SA, et al. HIV/AIDS in Sierra Leone: characterizing the hidden epidemic. AIDS Rev. 2018;20:105–14.
8.
go back to reference Yendewa GA, Poveda E, Lakoh S, et al. High prevalence of late-stage diagnosis in newly diagnosed HIV patients in Sierra Leone. Open Forum Infect Dis. 2018;5:ofy208.CrossRef Yendewa GA, Poveda E, Lakoh S, et al. High prevalence of late-stage diagnosis in newly diagnosed HIV patients in Sierra Leone. Open Forum Infect Dis. 2018;5:ofy208.CrossRef
9.
go back to reference Faye B, Mbow M, Cheikh Seck M, et al. Evaluation of PIMATM CD4 system for decentralization of immunological monitoring of HIV-infected patients in Senegal. PLoS One. 2016;11:e0154000.CrossRef Faye B, Mbow M, Cheikh Seck M, et al. Evaluation of PIMATM CD4 system for decentralization of immunological monitoring of HIV-infected patients in Senegal. PLoS One. 2016;11:e0154000.CrossRef
10.
go back to reference Angus DC, Seymour CW, Coopersmith CM, et al. A framework for the development and interpretation of different sepsis. Definitions and clinical criteria. Crit Care Med. 2016;44:e113–21.CrossRef Angus DC, Seymour CW, Coopersmith CM, et al. A framework for the development and interpretation of different sepsis. Definitions and clinical criteria. Crit Care Med. 2016;44:e113–21.CrossRef
14.
go back to reference Long R, Maycher B, Scalcini M, et al. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest. 1991;99:123.CrossRef Long R, Maycher B, Scalcini M, et al. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest. 1991;99:123.CrossRef
15.
go back to reference Barnes PF, Bloch AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324:1644.CrossRef Barnes PF, Bloch AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324:1644.CrossRef
16.
go back to reference Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV working group. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38:1454–63.CrossRef Volberding PA, Levine AM, Dieterich D, et al. Anemia in HIV working group. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38:1454–63.CrossRef
17.
go back to reference Naing C, Sandhu NK, Wai VN. The effect of malaria and HIV co-infection on anemia: a meta-analysis. Medicine (Baltimore). 2016;95:e3205.CrossRef Naing C, Sandhu NK, Wai VN. The effect of malaria and HIV co-infection on anemia: a meta-analysis. Medicine (Baltimore). 2016;95:e3205.CrossRef
18.
go back to reference O'Brien ME, Kupka R, Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40:219.CrossRef O'Brien ME, Kupka R, Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40:219.CrossRef
19.
go back to reference Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS. 1999;13:943–50.CrossRef Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS. 1999;13:943–50.CrossRef
20.
go back to reference Kujawski SA, Lamb MR, Lahuerta M, et al. Advanced human immunodeficiency virus disease at diagnosis in Mozambique and Swaziland. Open Forum Infect Dis. 2017;4:ofx156.CrossRef Kujawski SA, Lamb MR, Lahuerta M, et al. Advanced human immunodeficiency virus disease at diagnosis in Mozambique and Swaziland. Open Forum Infect Dis. 2017;4:ofx156.CrossRef
21.
go back to reference Gesesew HA, Ward P, Woldemichael K, Mwanri L. Late presentation for HIV care in Southwest Ethiopia in 2003-2015: prevalence, trend, outcomes and risk factors. BMC Infect Dis. 2018;18:59.CrossRef Gesesew HA, Ward P, Woldemichael K, Mwanri L. Late presentation for HIV care in Southwest Ethiopia in 2003-2015: prevalence, trend, outcomes and risk factors. BMC Infect Dis. 2018;18:59.CrossRef
22.
go back to reference Hønge BL, Jespersen S, Aunsborg J, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa. Pan Afr Med J. 2016;25:40.CrossRef Hønge BL, Jespersen S, Aunsborg J, et al. High prevalence and excess mortality of late presenters among HIV-1, HIV-2 and HIV-1/2 dually infected patients in Guinea-Bissau - a cohort study from West Africa. Pan Afr Med J. 2016;25:40.CrossRef
23.
go back to reference Yendewa GA. Hot news: new insights from IeDEA and COHERE on global trends in CD4 counts at ART initiation. AIDS Rev. 2018;20:174–5.PubMed Yendewa GA. Hot news: new insights from IeDEA and COHERE on global trends in CD4 counts at ART initiation. AIDS Rev. 2018;20:174–5.PubMed
24.
go back to reference Ousley J, Niyibizi AA, Wanjala S, et al. High proportions of patients with advanced HIV are antiretroviral therapy experienced: hospitalization outcomes from 2 sub-Saharan African sites. Clin Infect Dis. 2018;66:S126–32.CrossRef Ousley J, Niyibizi AA, Wanjala S, et al. High proportions of patients with advanced HIV are antiretroviral therapy experienced: hospitalization outcomes from 2 sub-Saharan African sites. Clin Infect Dis. 2018;66:S126–32.CrossRef
25.
go back to reference Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14:281–90.CrossRef Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14:281–90.CrossRef
26.
go back to reference Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897–908.CrossRef Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897–908.CrossRef
27.
go back to reference Fleishman JA, Yehia BR, Moore RD, Gebo KA. The economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48:1071–9.CrossRef Fleishman JA, Yehia BR, Moore RD, Gebo KA. The economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48:1071–9.CrossRef
28.
go back to reference Chalasani N, Wilcox CM. Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome. Hepatology. 1996;23:728–33.CrossRef Chalasani N, Wilcox CM. Etiology, evaluation, and outcome of jaundice in patients with acquired immunodeficiency syndrome. Hepatology. 1996;23:728–33.CrossRef
29.
go back to reference Ocama P, Katwere M, Piloya T, et al. The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci. 2008;8:8–12.PubMedPubMedCentral Ocama P, Katwere M, Piloya T, et al. The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci. 2008;8:8–12.PubMedPubMedCentral
30.
go back to reference Eskild A, Magnus P, Petersen G, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS. 1992;6:571.CrossRef Eskild A, Magnus P, Petersen G, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS. 1992;6:571.CrossRef
31.
go back to reference Hoffmann CJ, Seaberg EC, Young S, et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS. 2009;23:1881.CrossRef Hoffmann CJ, Seaberg EC, Young S, et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS. 2009;23:1881.CrossRef
32.
go back to reference Drake A, Mijch A, Sasadeusz J. Immune reconstitution hepatitis in HIV and hepatitis B co infection, despite lamivudine as part of HAART. Clin Infect Dis. 2004;39:129–32 Hoffmann CJ.CrossRef Drake A, Mijch A, Sasadeusz J. Immune reconstitution hepatitis in HIV and hepatitis B co infection, despite lamivudine as part of HAART. Clin Infect Dis. 2004;39:129–32 Hoffmann CJ.CrossRef
33.
go back to reference Hoffmann CJ, Charalambous S, Thio CL, et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS. 2007;21:1301–8.CrossRef Hoffmann CJ, Charalambous S, Thio CL, et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS. 2007;21:1301–8.CrossRef
34.
go back to reference Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study. Lancet. 2002;360:1921.CrossRef Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study. Lancet. 2002;360:1921.CrossRef
35.
go back to reference Pinato DJ, Allara E, Chen TY, et al. Influence of HIV infection on the natural history of hepatocellular carcinoma: results from a global multicohort study. J Clin Oncol. 2019;37:296–304.CrossRef Pinato DJ, Allara E, Chen TY, et al. Influence of HIV infection on the natural history of hepatocellular carcinoma: results from a global multicohort study. J Clin Oncol. 2019;37:296–304.CrossRef
36.
go back to reference Yendewa GA, Sahr F, Aguilera A, et al. Seroprevalence of hepatitis B, hepatitis C and human T-cell lymphotropic virus infections in human immunodeficiency virus-infected patients in Sierra Leone. Am J Trop Med Hyg. 2019;100:1521–4.CrossRef Yendewa GA, Sahr F, Aguilera A, et al. Seroprevalence of hepatitis B, hepatitis C and human T-cell lymphotropic virus infections in human immunodeficiency virus-infected patients in Sierra Leone. Am J Trop Med Hyg. 2019;100:1521–4.CrossRef
37.
go back to reference Yendewa GA, Sahr F, Lakoh S, et al. Prevalence of drug resistance mutations among ART-naïve and experienced HIV-infected patients in Sierra Leone. J Antimicrob Chemother. 2019;74:2024–9.CrossRef Yendewa GA, Sahr F, Lakoh S, et al. Prevalence of drug resistance mutations among ART-naïve and experienced HIV-infected patients in Sierra Leone. J Antimicrob Chemother. 2019;74:2024–9.CrossRef
Metadata
Title
Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study
Authors
Sulaiman Lakoh
Darlinda F. Jiba
Joseph E. Kanu
Eva Poveda
Angel Salgado-Barreira
Foday Sahr
Momodu Sesay
Gibrilla F. Deen
Tom Sesay
Wadzani Gashau
Robert A. Salata
George A. Yendewa
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7614-3

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue